Zuojin Pill enhances gastrointestinal motility by modulating the pacemaker potentials in interstitial cells of Cajal through multiple signaling pathways
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- INTERNATIONAL JOURNAL OF MEDICAL SCIENCES21(15) · pp.2883 · 2024
- 피인용
- Web of Science 3Scopus 3
- FWCI (Scopus)
- 0.55
- JCR IF
- JCR 2023 3.2
- ISSN
- 1449-1907
저자
- 이주은제1저자
- Ko, Seok JaeKyung Hee Univ, Grad Sch, Dept Clin Korean Med, Seoul 02447, South Korea
- 최나리Pusan Natl Univ, Sch Korean Med, Dept Longev & Biofunct Med, Yangsan 50612, South Korea
- 최우균
- 서무진
- 구승현
- Jung, Daehwa
- Lee, Min Jae
- Lee, Jong Hwan
- Park, Jae-Woo교신저자Kyung Hee Univ, Grad Sch, Dept Clin Korean Med, Seoul 02447, South Korea
- 김병주교신저자Pusan Natl Univ, Sch Korean Med, Dept Longev & Biofunct Med, Yangsan 50612, South Korea
초록
Zuojin Pill (ZJP) is a traditional herbal preparation used to treat various gastrointestinal (GI) disorders. The purpose of this study was to elucidate the underlying cellular and molecular mechanisms by evaluating the effects of ZJP on the pacemaker activity of isolated interstitial cells of Cajal (ICCs) and on in vivo GI motility in mice. We isolated ICCs from mouse small intestine and measured pacemaker potentials by whole-cell patch clamping as well as intracellular calcium signaling by microfluorometry. Intestinal transit rate (ITR) was measured by Evans Blue migration. Administration of ZJP depolarized ICCs and reduced the amplitude and frequency of pacemaker potentials. Pretreatment with the 5-HT4 receptor antagonist RS39604, administration of the muscarinic M3 receptor antagonist 4-DAMP, or intracellular perfusion of the G-protein inhibitor GDP-beta-S blocked ZJP-induced ICCs depolarization. In addition, external calcium-free medium and administration of the Ca2+-ATPase inhibitor thapsigargin, ZJP-induced ICCs depolarization was inhibited in the presence of the phospholipase C (PLC) inhibitor U-73122, IP3-dependent Ca2+ release inhibitor xestospongin C, or various mitogen-activated protein kinase (MAPK) inhibitors. Alternatively, ZJP-induced ICCs depolarization in the presence of protein kinase C (PKC) inhibitors. Furthermore, ZJP reversed the reduction of ITR caused by loperamide (Imodium) and normalized the ITR abnormality of two etiologically distinct GI motility disorder (GMD) mouse models. Finally, ZJP increased serum concentrations of the pro-peristalsis factors motilin and substance P. Our results suggest that ZJP depolarizes ICCs via 5-HT4 or muscarinic M3 receptor pathways (but not PKC-dependent pathways), leading to enhanced GI motility.
키워드
Zuojin PillGastrointestinal DisordersInterstitial Cells of CajalPacemaker PotentialIntestinal Transit RateETHANOL EXTRACTPROTEINRECEPTORSSYSTEM
식별자
- Scopus EID
- 2-s2.0-85209887545
- WoS UID
- 001363267400001



로그인
연구물 목록으로